About: Sandra M. Swain

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sandra M. Swain Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American oncologist

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) 연구원 (ko) 研究者 (ja) araştırmacı (tr) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) American oncologist (en) oncoloog (nl) طبيبة أورام أمريكية (ar) oncóloga estadounidense (es)
exact match	wds:Q37839297-3B5FC403-05BA-4AE5-B0A0-A0CFFDF10750
exact match	https://scigraph.springernature.com/person.07442661237.16
rdfs:label	Sandra M Swain (nl) Sandra M Swain (sl) Sandra M. Swain (en) Sandra M. Swain (es) Sandra M. Swain (it) Sandra M. Swain (sq) ساندرا ام. سواین (fa) സാന്ദ്ര എം. സ്വെയിൻ (ml)
skos:prefLabel	Sandra M Swain (nl) Sandra M Swain (sl) Sandra M. Swain (en) Sandra M. Swain (es) Sandra M. Swain (it) Sandra M. Swain (sq) ساندرا ام. سواین (fa) സാന്ദ്ര എം. സ്വെയിൻ (ml)
name	Sandra M Swain (nl) Sandra M Swain (sl) Sandra M. Swain (en) Sandra M. Swain (es) Sandra M. Swain (it) Sandra M. Swain (sq) ساندرا ام. سواین (fa) സാന്ദ്ര എം. സ്വെയിൻ (ml)
Scopus author ID	wds:Q37839297-5BF795CE-0253-46FC-B75D-420C42EFD73E
Scopus author ID	35379638200
given name	wds:Q37839297-CEA49237-B53C-4139-A08F-A521DF3FD1A4
given name	Sandra
image	wds:Q37839297-A6B11DE7-72AA-4E99-A625-7E43EAD673CC
instance of	wds:Q37839297-9872EDAB-5B9C-4C24-80CA-5EB3923EC825
image
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q37839297-8EFB5C26-7E7A-4227-BBBB-5EFDA511EC67
Google Knowledge Graph ID	http://g.co/kg/g/11gc9ggxtq
Google Knowledge Graph ID	/g/11gc9ggxtq
skos:altLabel	Sandra Swain (en)
occupation	wds:Q37839297-B5EA2323-3F4C-4F8F-857A-AE80DE527BC7 wds:Q37839297-BF6D2304-5C27-47FE-8D7E-BEB3CF3E71E2
employer	wds:Q37839297-16d0fc88-6ce0-4b09-b50c-c3aa9e010ce8
NUKAT ID	wds:Q37839297-3D5CBD46-87BC-4CCA-8E54-F4ECD10F2747
sex or gender	wds:Q37839297-EE7B8FA1-B56F-4574-BDE5-D7D38451A0DF
ISNI	wds:Q37839297-B6C6008B-9F99-4916-81D1-12279851689D
VIAF ID	wds:Q37839297-4FA7E10F-F1D0-4D5F-8CD7-F1F5947FD7B5
GND ID	wds:Q37839297-54b52401-bba4-4d5e-8014-c2871c020e71
Library of Congress authority ID	wds:Q37839297-4863F37C-D861-4E67-98A2-4B9BA4C6E93F
residence	wds:Q37839297-E6DA201F-D003-4D7C-B28A-667273264610
date of birth	wds:Q37839297-232EF7DD-84E7-44C6-9232-32FACE36B3AC
educated at	wds:Q37839297-3A11EA16-8820-412F-BEEC-9BC7E07DB4AC wds:Q37839297-8E7894FA-1C84-49B4-B5D0-C70919905F7D
family name	wds:Q37839297-90F7E8F4-7FF4-47F6-93F0-8B4933FA77EC
WorldCat Identities ID (superseded)	wds:Q37839297-A43CF17B-B75E-4268-97C3-747E155E1E78
VIAF ID	http://viaf.org/viaf/66789647
GND ID	https://d-nb.info/gnd/1136982418
Library of Congress authority ID	http://id.loc.gov/authorities/names/no92004095
occupation	oncologist researcher
employer	Uniformed Services University of the Health Sciences
NUKAT ID	n2016013024
sex or gender	female organism
ISNI	0000000039243107
VIAF ID	66789647
GND ID	1136982418
Library of Congress authority ID	no92004095
residence	Bethesda
date of birth	1950-01-01 00:00:00Z (xsd:dateTime)
educated at	University of North Carolina at Chapel Hill University of Florida College of Medicine
family name	Swain
WorldCat Identities ID (superseded)	lccn-no92004095
ORCID iD	wds:Q37839297-DD12ECD0-358E-4878-BA99-55504F73786F
Dimensions author ID	wds:Q37839297-66ABDA8A-FD06-447C-B757-76D0161B766F
ORCID iD	https://orcid.org/0000-0002-1320-3830
ORCID iD	0000-0002-1320-3830
Dimensions author ID	07442661237.16
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37839297 Sandra M. Swain https://fa.wikipedia.org/wiki/%D8%B3%D8%A7%D9%86%D8%AF%D8%B1%D8%A7_%D8%A7%D9%85._%D8%B3%D9%88%D8%A7%DB%8C%D9%86 https://ml.wikipedia.org/wiki/%E0%B4%B8%E0%B4%BE%E0%B4%A8%E0%B5%8D%E0%B4%A6%E0%B5%8D%E0%B4%B0_%E0%B4%8E%E0%B4%82._%E0%B4%B8%E0%B5%8D%E0%B4%B5%E0%B5%86%E0%B4%AF%E0%B4%BF%E0%B5%BB
is author of	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software